| Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 1974 | 2016 |
| Comprehensive molecular portraits of invasive lobular breast cancer G Ciriello, ML Gatza, AH Beck, MD Wilkerson, SK Rhie, A Pastore, ... Cell 163 (2), 506-519, 2015 | 1758 | 2015 |
| Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings K Kolandaivelu, R Swaminathan, WJ Gibson, VB Kolachalama, ... Circulation 123 (13), 1400-1409, 2011 | 817 | 2011 |
| BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma P Bandopadhayay, G Bergthold, B Nguyen, S Schubert, S Gholamin, ... Clinical Cancer Research 20 (4), 912-925, 2014 | 378 | 2014 |
| MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism P Bandopadhayay, LA Ramkissoon, P Jain, G Bergthold, J Wala, R Zeid, ... Nature genetics 48 (3), 273-282, 2016 | 267 | 2016 |
| The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis WJ Gibson, EA Hoivik, MK Halle, A Taylor-Weiner, AD Cherniack, A Berg, ... Nature genetics 48 (8), 848-855, 2016 | 196 | 2016 |
| EGLN1 inhibition and rerouting of α-ketoglutarate suffice for remote ischemic protection BA Olenchock, J Moslehi, AH Baik, SM Davidson, J Williams, WJ Gibson, ... Cell 164 (5), 884-895, 2016 | 144 | 2016 |
| SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis Y Zhang, L Xie, SK Gunasekar, D Tong, A Mishra, WJ Gibson, C Wang, ... Nature cell biology 19 (5), 504-517, 2017 | 132 | 2017 |
| Timing of Myocardial Trpm7 Deletion During Cardiogenesis Variably Disrupts Adult Ventricular Function, Conduction, and Repolarization R Sah, P Mesirca, X Mason, W Gibson, C Bates-Withers, ... Circulation 128 (2), 101-114, 2013 | 127 | 2013 |
| Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis JW Franses, NC Drosu, WJ Gibson, VC Chitalia, ER Edelman International journal of cancer 133 (6), 1334-1344, 2013 | 125 | 2013 |
| Landscape of genomic alterations in pituitary adenomas WL Bi, P Horowitz, NF Greenwald, M Abedalthagafi, PK Agarwalla, ... Clinical Cancer Research 23 (7), 1841-1851, 2017 | 122 | 2017 |
| ARID1A and TERT promoter mutations in dedifferentiated meningioma MS Abedalthagafi, WL Bi, PH Merrill, WJ Gibson, MF Rose, Z Du, ... Cancer genetics 208 (6), 345-350, 2015 | 83 | 2015 |
| Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability BR Paolella, WJ Gibson, LM Urbanski, JA Alberta, TI Zack, ... Elife 6, e23268, 2017 | 78 | 2017 |
| Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities CA Nichols, WJ Gibson, MS Brown, JA Kosmicki, JP Busanovich, H Wei, ... Nature communications 11 (1), 2517, 2020 | 75 | 2020 |
| Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance AB Baker, WJ Gibson, VB Kolachalama, M Golomb, L Indolfi, C Spruell, ... Journal of the American College of Cardiology 59 (17), 1551-1560, 2012 | 65 | 2012 |
| Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients A Berg, EA Hoivik, S Mjøs, F Holst, HMJ Werner, IL Tangen, ... Oncotarget 6 (2), 1327, 2015 | 63 | 2015 |
| Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years V Kunadian, C Harrigan, C Zorkun, AM Palmer, KJ Ogando, LH Biller, ... Journal of thrombosis and thrombolysis 27, 316-328, 2009 | 62 | 2009 |
| Endovascular devices/catheter platforms and methods for achieving congruency in sequentially deployed devices K Kolandaivelu, RV Swaminathan, WJ Gibson, ER Edelman US Patent App. 12/819,478, 2010 | 45 | 2010 |
| Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis WJ Gibson, T Nafee, R Travis, M Yee, M Kerneis, M Ohman, CM Gibson Journal of thrombosis and thrombolysis, 1-9, 2020 | 43 | 2020 |
| Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction V Kunadian, C Zorkun, SP Williams, LH Biller, AM Palmer, KJ Ogando, ... Journal of thrombosis and thrombolysis 26, 234-242, 2008 | 36 | 2008 |
Rameen BeroukhimDana-Farber Cancer Institute, Harvard Medical SchoolVerified email at broadinstitute.org
